Repligen Corp.

Research and Markets Offers Report Bipolar Disorder - Drug Pipeline Analysis and Market Forecasts to 2015
Wireless News; 12/19/2009; 735 words; ...for the treatment of bipolar disorder. Companies Mentioned: - Johnson & Johnson - Dainippon Sumitomo Pharma - Repligen Corp. - Lundbeck - Alexza Pharmaceuticals Report information: http://www.researchandmarkets.com/research/65e4b4...

Other News To Note.
BIOWORLD Today; 12/16/2009; 888 words; ...article&forceid=52861).) o Life Technologies Corp., of Carlsbad, Calif., completed its acquisition...cells, is getting ready for Phase III development. o Repligen Corp., of Waltham, Mass., said it received $731,000...

Research and Markets Adds Report: Bipolar Disorder - Drug Pipeline Analysis and Market Forecasts to 2015.(Report)
Health & Beauty Close-Up; 12/15/2009; 1217 words; ...classes for the treatment of bipolar disorder. Companies Mentioned: - Johnson & Johnson - Dainippon Sumitomo Pharma - Repligen Corp. - Lundbeck - Alexza Pharmaceuticals Report information: http://www.researchandmarkets.com/research/65e4b4...

REPLIGEN FILES 10-Q (QUARTERLY REPORT)
US Fed News Service, Including US State News; 12/8/2009; 282 words; WASHINGTON, Dec. 8 -- Repligen Corp., Waltham, Mass., has filed a Form 10-Q on Nov. 5 for the second quarter ending Sept. 30 with the U.S. Securities and...

REPLIGEN REPORTS ACQUISITION BY DIRECTOR COOPER (Massachusetts)
US Fed News Service, Including US State News; 12/1/2009; 292 words; WASHINGTON, Dec. 1 -- Repligen Corp. (RGEN), Waltham, Mass., has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial...